Skip to content
  • AFR Inc. Logo in Blue and Gray ColorLogo
  • Home
  • AFR Platform
  • Contact us
  • About us
  • Sign In
  • Menu
Home » Uncategorized » Page 60

Category Archives: Uncategorized

How Dana Walden could defy critics and become Disney’s first female CEO

Walden has proven herself as a top TV executive, but some ex-Disney executives question whether her resume is suitable for the Disney CEO job.

Continue reading→

Macy’s hasn’t closed 150 stores yet. But Target, Kohl’s CEOs already smell opportunity

Macy’s closures of about 150 stores could put up to $2 billion in annual sales up for grabs for other retailers.

Continue reading→

Bally’s shareholders wage battle over ownership, ‘unfunded development projects’

Key investors are fighting back against Bally’s Chairman Soo Kim, and his offer to buy the casino company and take it private.

Continue reading→

Health insurer stocks slide as final Medicare Advantage rates disappoint

The rate adds more pressure on insurers already grappling with high medical costs and uncertainty after the cyberattack on UnitedHealth Group’s tech unit.

Continue reading→

Why streamers are shrinking their content libraries

Data from Fandom suggests where the major streaming platforms are best poised to specialize based on current viewership.

Continue reading→

Disney’s cinematic drought may have opened a door for activist investor Peltz

Other than “Avatar: The Way of Water,” Disney has not had a movie generate more than $1 billion since the last Star Wars movies in […]

Continue reading→

Hyundai considering hybrid vehicle production at $7.6 billion Georgia EV plant

The reassessment comes amid slower-than-excepted adoption of EVs, as well as the Biden administration revising emissions rules.

Continue reading→

Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart

The results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that they shrink critical muscle mass.

Continue reading→

Novo Nordisk’s $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests

Researchers found Novo Nordisk’s Ozempic could be manufactured for an estimated 89 cents to $4.73 for a month’s supply, figures that include a profit margin.

Continue reading→

Largest U.S. sportsbooks join forces to tackle problem gambling

FanDuel, DraftKings, BetMGM, Penn Entertainment, Fanatics Betting & Gaming, Hard Rock Digital and bet365 will form the Responsible Online Gaming Association.

Continue reading→

Post navigation

« Previous 1 … 55 56 57 58 59 60 61 62 63 64 65 … 322 Next »

AFR Platform

  • Entrepreneurship
  • Financial Service
  • Industry
  • Investing
  • Small Business
  • SPACs
  • Stock Trading
  • More Indexes

Genres

  • Business
  • Commodity
  • Market News
  • Politics
  • Sports
  • Technology

Recent Topics

  • Apple
    3 years ago
  • SB Platform
    3 years ago
  • Inflation Implications
    3 years, 1 month ago
  • Paying Off Debt
    3 years, 2 months ago
  • Market Volatility
    3 years, 2 months ago

Membership

  • Log In
  • My Account
  • My Profile
  • Terms
  • Privacy Policy
AFR Edu., © 2025
A SiteOrigin Theme